Among the identified Setdb1 genomic targets, Ankrd1 appeared of particular interest due to its involvement in myogenesis [41] and its Wnt/β-Catenin-dependent induction in mammary tumours [54]. This evidence concerns the gene ANKRD1 and breast cancer.